Large scale neonatal screening programs for NSHL have been increasingly implemented in China since the introduction a regulatory agency approved DNA chip assay, which detects 9 mutations in GJB2, SLC26A4, mitochondria, and GJB320. The gene discussed is SLC26A4; the disease is nodular sclerosis classical Hodgkin lymphoma.